Next earnings date: 26 Aug 2025
Biomerica, Inc. – NASDAQ:BMRA
Biomerica stock price today
$2.85
+2.53
+803.61%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Biomerica stock price monthly change
-11.74%
month
Biomerica stock price quarterly change
-11.74%
quarter
Biomerica stock price yearly change
-73.75%
year
Biomerica key metrics
Market Cap | 4.55M |
Enterprise value | 21.34M |
P/E | -4.35 |
EV/Sales | 1.32 |
EV/EBITDA | -4.30 |
Price/Sales | 1.56 |
Price/Book | 3.47 |
PEG ratio | -0.13 |
EPS | -0.48 |
Revenue | 8.53M |
EBITDA | -6.65M |
Income | -7.11M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -34.58% |
Oper. margin | -34.82% |
Gross margin | 16.11% |
EBIT margin | -34.82% |
EBITDA margin | -77.89% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBiomerica stock price history
Biomerica stock forecast
Biomerica financial statements
| May 2022 | 5.30M | -1.75M | -33.18% |
|---|---|---|---|
| Feb 2023 | 1.11M | -1.64M | -148.44% |
| May 2023 | 1.10M | -1.79M | -161.72% |
| Feb 2024 | 1.01M | -1.91M | -188.59% |
| Nov 2022 | 9907547 | 2.66M | 26.9% |
|---|---|---|---|
| Feb 2023 | 8210168 | 2.22M | 27.09% |
| May 2023 | 14454000 | 2.73M | 18.89% |
| Feb 2024 | 10342000 | 2.53M | 24.5% |
| May 2022 | -4.25M | -24.35K | 38.18K |
|---|---|---|---|
| Feb 2023 | -1.72M | -5.76K | 24.75K |
| May 2023 | -962.67K | -14.14K | 7.34M |
| Feb 2024 | -1.80M | -16K | 0 |
Biomerica alternative data
| Aug 2023 | 64 |
|---|---|
| Sep 2023 | 62 |
| Oct 2023 | 62 |
| Nov 2023 | 62 |
| Dec 2023 | 62 |
| Jan 2024 | 62 |
| Feb 2024 | 62 |
| Mar 2024 | 62 |
| Apr 2024 | 62 |
| May 2024 | 62 |
| Jun 2024 | 62 |
| Jul 2024 | 62 |
Biomerica other data
13.05%
-12.84%
of BMRA is owned by hedge funds
1.75M
-1.72M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2023 | 7528 | 0 |
| Apr 2023 | 11400 | 0 |
| May 2023 | 4200 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | IRANI ZACKARY S. director, officer: Chief Execut.. | Common Stock | 200 | $1.55 | $310 | ||
Purchase | IRANI ZACKARY S. director, officer: Chief Execut.. | Common Stock | 500 | $1.61 | $805 | ||
Purchase | IRANI ZACKARY S. director, officer: Chief Execut.. | Common Stock | 1,700 | $1.17 | $1,989 | ||
Purchase | IRANI ZACKARY S. director, officer: Chief Execut.. | Common Stock | 500 | $1.27 | $635 | ||
Purchase | IRANI ZACKARY S. director, officer: Chief Execut.. | Common Stock | 300 | $1.39 | $417 | ||
Purchase | IRANI ZACKARY S. director, officer: Chief Execut.. | Common Stock | 1,000 | $1.36 | $1,360 | ||
Purchase | IRANI ZACKARY S. director, officer: Chief Execut.. | Common Stock | 1,800 | $1.34 | $2,412 | ||
Purchase | IRANI ZACKARY S. director, officer: Chief Execut.. | Common Stock | 2,600 | $1.31 | $3,406 | ||
Purchase | IRANI ZACKARY S. director, officer: Chief Execut.. | Common Stock | 7,000 | $1.26 | $8,820 | ||
Purchase | BARBIERI ALLEN officer: Executiv.. | Common Stock | 1,538 | $2.94 | $4,522 |
| Patent |
|---|
Application Filling date: 21 Aug 2020 Issue date: 10 Jun 2021 |
Application COMPOSITIONS, DEVICES, AND METHODS OF ATTENTION DEFICIT DISORDER/ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADD/ADHD) SENSITIVITY TESTING Filling date: 14 Jun 2019 Issue date: 2 Jan 2020 |
Application Filling date: 16 Apr 2019 Issue date: 8 Aug 2019 |
Application Filling date: 8 Jan 2019 Issue date: 8 Aug 2019 |
Application Filling date: 12 Dec 2018 Issue date: 8 Aug 2019 |
-
What's the price of Biomerica stock today?
One share of Biomerica stock can currently be purchased for approximately $2.85.
-
When is Biomerica's next earnings date?
Biomerica, Inc. is estimated to report earnings on Tuesday, 26 Aug 2025.
-
Does Biomerica pay dividends?
No, Biomerica does not pay dividends.
-
How much money does Biomerica make?
Biomerica has a market capitalization of 4.55M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1.42% to 5.42M US dollars.
-
What is Biomerica's stock symbol?
Biomerica, Inc. is traded on the NASDAQ under the ticker symbol "BMRA".
-
What is Biomerica's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Biomerica?
Shares of Biomerica can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Biomerica's key executives?
Biomerica's management team includes the following people:
- Mr. Steven Sloan Chief Financial Officer & Treasurer(age: 55, pay: $166,670)
- Mr. Zackary S. Irani Chairman & Chief Executive Officer(age: 59, pay: $136,610)
- Mr. Allen C. Barbieri Executive Vice-Chairman & Corporation Sec.(age: 67, pay: $90,000)
-
How many employees does Biomerica have?
As Jul 2024, Biomerica employs 62 workers.
-
When Biomerica went public?
Biomerica, Inc. is publicly traded company for more then 41 years since IPO on 7 Sep 1984.
-
What is Biomerica's official website?
The official website for Biomerica is biomerica.com.
-
Where are Biomerica's headquarters?
Biomerica is headquartered at 17571 Von Karman Avenue, Irvine, CA.
-
How can i contact Biomerica?
Biomerica's mailing address is 17571 Von Karman Avenue, Irvine, CA and company can be reached via phone at +94 96452111.
Biomerica company profile:
Biomerica, Inc.
biomerica.comExchange:
NASDAQ
Full time employees:
64
Industry:
Medical - Devices
Sector:
Healthcare
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
17571 Von Karman Avenue
Irvine, CA 92614
Irvine, CA 92614
CIK: 0000073290
ISIN: US09061H3075
CUSIP: 09061H307
